SET 企业启动SPI340BSM服务,以发现340B所涉实体的可疑采购模式。 SET Enterprises launches SPI340B℠ service to detect suspicious purchasing patterns among 340B covered entities.
SET企业引进了SPI340BSM,这项服务可查出340B所涉实体的可疑采购模式,以及根据340B药物定价方案获得折扣药品的保健组织。 SET Enterprises has introduced SPI340B℠, a service that detects suspicious purchasing patterns among 340B covered entities, healthcare organizations receiving discounted medications under the 340B Drug Pricing Program. SPI340BSM旨在帮助制药和生物技术制造商确保其产品按预定用途使用,只为符合条件的病人使用。 SPI340B℠ aims to help pharmaceutical and biotech manufacturers ensure their products are used as intended, only for eligible patients. 服务利用专有算法和模型分析制造商的销售数据,并确定显示潜在转移的具体采购模式。 The service uses proprietary algorithms and models to analyze manufacturers' sales data and identify specific purchasing patterns that signal potential diversion. 通过发现这种模式,制造商可以减少收入流失和尽量减少投资。 By detecting such patterns, manufacturers can reduce revenue leakage and minimize investments.